Elucidating effects of long-term expression of HIV-1 Nef on astrocytes by microarray, promoter, and literature analyses.
暂无分享,去创建一个
Thomas Werner | Alexander Hahn | T. Werner | Alexander Hahn | R. Brack-Werner | Ruth Brack-Werner | Susanne Kramer-Hämmerle | S. Kramer-Hämmerle | Susanne Kramer-Hämmerle
[1] B. Peterlin,et al. Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[2] V. Ovod,et al. Cellular localization of Nef expressed in persistently HIV‐1 -infected low‐producer astrocytes , 1992, AIDS.
[3] R. Siliciano,et al. The challenge of viral reservoirs in HIV-1 infection. , 2002, Annual review of medicine.
[4] T. Smithgall,et al. HIV-1 Nef Promotes Survival of Myeloid Cells by a Stat3-dependent Pathway , 2001, The Journal of Biological Chemistry.
[5] Francisco González-Scarano,et al. The neuropathogenesis of AIDS , 2005, Nature Reviews Immunology.
[6] H. Ford,et al. Transcriptional Control of the Cell Cycle in Mammary Gland Development and Tumorigenesis , 2004, Journal of Mammary Gland Biology and Neoplasia.
[7] T. Smithgall,et al. HIV-1 Nef Promotes Survival of TF-1 Macrophages by Inducing Bcl-XL Expression in an Extracellular Signal-regulated Kinase-dependent Manner* , 2004, Journal of Biological Chemistry.
[8] Giuseppe Cibelli,et al. Regulation of life and death by the zinc finger transcription factor Egr‐1 , 2002, Journal of cellular physiology.
[9] G. Stewart,et al. HIV type 1 Nef increases the association of T cell receptor (TCR)-signaling molecules with T cell rafts and promotes activation-induced raft fusion. , 2004, AIDS research and human retroviruses.
[10] G. Robichaud,et al. Interference of HIV‐1 Nef in the sphingomyelin transduction pathway activated by tumour necrosis factor‐α in human glial cells , 1997, AIDS.
[11] F. Kirchhoff,et al. Nef Associates with p21-Activated Kinase 2 in a p21-GTPase-Dependent Dynamic Activation Complex within Lipid Rafts , 2004, Journal of Virology.
[12] E. Shumay,et al. Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes. , 1999, AIDS.
[13] M. Robert-Guroff,et al. Deletion of N-terminal myristoylation site of HIV Nef abrogates both MHC-1 and CD4 down-regulation. , 2001, Immunology letters.
[14] T. Werner,et al. A novel method to develop highly specific models for regulatory units detects a new LTR in GenBank which contains a functional promoter. , 1997, Journal of molecular biology.
[15] Thomas Werner,et al. Functional promoter modules can be detected by formal models independent of overall nucleotide sequence similarity , 1999, Bioinform..
[16] E. Shumay,et al. HIV type 1 Nef promotes neoplastic transformation of immortalized neural cells. , 2001, AIDS research and human retroviruses.
[17] A. Gatignol,et al. HIV-1 TAR RNA: the target of molecular interactions between the virus and its host. , 2005, Current HIV research.
[18] W. Wong,et al. Molecular diversity of astrocytes with implications for neurological disorders. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. McMichael,et al. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. , 2001, Immunity.
[20] G. Robichaud,et al. HIV type 1 nef gene inhibits tumor necrosis factor alpha-induced apoptosis and promotes cell proliferation through the action of MAPK and JNK in human glial cells. , 2000, AIDS research and human retroviruses.
[21] D. Purcell,et al. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. , 2003, Current HIV research.
[22] F. Spadaro,et al. HIV‐1 Nef triggers Vav‐mediated signaling pathway leading to functional and morphological differentiation of dendritic cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] L Yue,et al. Pathway and ontology analysis: emerging approaches connecting transcriptome data and clinical endpoints. , 2005, Current molecular medicine.
[24] J. Segovia,et al. Primary astrocytes retrovirally transduced with a tyrosine hydroxylase transgene driven by a glial‐specific promoter elicit behavioral recovery in experimental Parkinsonism , 2000, Journal of neuroscience research.
[25] D. Bigner,et al. Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas , 1981, Journal of neuropathology and experimental neurology.
[26] J. O'Callaghan,et al. Induction of gp130-related Cytokines and Activation of JAK2/STAT3 Pathway in Astrocytes Precedes Up-regulation of Glial Fibrillary Acidic Protein in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Neurodegeneration , 2004, Journal of Biological Chemistry.
[27] R. Brack-Werner. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. , 1999, AIDS.
[28] B. Gazzard,et al. Where does HIV live? , 2004, The New England journal of medicine.
[29] T. Werner,et al. Linking disease-associated genes to regulatory networks via promoter organization , 2005, Nucleic acids research.